Post by Rebrain.

✨ 𝗣𝘂𝗯𝗹𝗶𝘀𝗵𝗲𝗱 𝗶𝗻 𝗡𝗲𝘂𝗿𝗼𝘀𝘂𝗿𝗴𝗲𝗿𝘆: 𝗥𝗲𝗯𝗿𝗔𝗜𝗻 𝗼𝗽𝗲𝗻𝘀 𝗮 𝗻𝗲𝘄 𝗲𝗿𝗮 𝗶𝗻 𝗗𝗲𝗲𝗽 𝗕𝗿𝗮𝗶𝗻 𝗦𝘁𝗶𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻✨ RebrAIn is proud to announce that the results of the 𝗺𝘂𝗹𝘁𝗶𝗰𝗲𝗻𝘁𝗲𝗿 𝗽𝗵𝗮𝘀𝗲 𝟮 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹 𝗢𝗣𝗧𝗜𝗩𝗜𝗠 have just been published in the prestigious journal Neurosurgery. This study validates the 𝗲𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲𝗻𝗲𝘀𝘀 𝗼𝗳 𝗼𝘂𝗿 𝗔𝗜 𝗮𝗹𝗴𝗼𝗿𝗶𝘁𝗵𝗺 to guide DBS in the treatment of essential tremor, under general anesthaesia and without the need for invasive intraoperative controls. 👉 𝗞𝗲𝘆 𝗿𝗲𝘀𝘂𝗹𝘁𝘀: • Mean tremor improvement of 𝟲𝟭.𝟯% (Fahn-Tolosa-Marin scale) • Tremor amplitude reduction up to 𝟴𝟰% (accelerometry) • Quality of life improvement of 𝟱𝟱% (mPDQ-39)   These findings confirm that RebrAIn’s algorithm enables automated, reproducible, and patient-specific stereotactic targeting 𝘂𝘀𝗶𝗻𝗴 𝗼𝗻𝗹𝘆 𝗮 𝘀𝘁𝗮𝗻𝗱𝗮𝗿𝗱 𝟯𝗗 𝗧𝟭 𝗠𝗥𝗜. A breakthrough that could 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺 𝗗𝗕𝗦 𝗽𝗿𝗮𝗰𝘁𝗶𝗰𝗲 𝗮𝗻𝗱 𝗲𝘅𝗽𝗮𝗻𝗱 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗮𝗰𝗰𝗲𝘀𝘀 𝘁𝗼 𝘁𝗵𝗶𝘀 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗳𝗼𝗿 𝘀𝗲𝘃𝗲𝗿𝗲 𝘁𝗿𝗲𝗺𝗼𝗿. 🔗 Read the full article on Neurosurgery: [https://lnkd.in/e8PK8W9p] We warmly thank all authors, researchers, and clinicians who contributed to this work, marking a key milestone towards more precise, safer, and accessible functional neurosurgery. #Neurosurgery #Innovation #AI #MedTech #Neurology #DeepBrainStimulation